Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMZN NASDAQ:DXCM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMZNAmazon.com$268.07-0.1%$238.43$196.00▼$278.56$2.88T1.4648.45 million shs16.44 million shsDXCMDexCom$72.24+0.5%$63.46$54.11▼$89.98$27.99B1.45.28 million shs3.11 million shsThe 10 Best AI Stocks to Own in 2026Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMZNAmazon.com+1.30%+0.46%+7.42%+27.77%+33.48%DXCMDexCom+0.64%+24.35%+14.86%-1.61%-15.30%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMZNAmazon.com$268.07-0.1%$238.43$196.00▼$278.56$2.88T1.4648.45 million shs16.44 million shsDXCMDexCom$72.24+0.5%$63.46$54.11▼$89.98$27.99B1.45.28 million shs3.11 million shsThe 10 Best AI Stocks to Own in 2026Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMZNAmazon.com+1.30%+0.46%+7.42%+27.77%+33.48%DXCMDexCom+0.64%+24.35%+14.86%-1.61%-15.30%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMZNAmazon.com 2.95Moderate Buy$312.6616.63% UpsideDXCMDexCom 2.92Moderate Buy$82.2113.79% UpsideCurrent Analyst Ratings BreakdownLatest DXCM and AMZN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/20/2026AMZNAmazon.com Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight$313.00 ➝ $312.005/18/2026DXCMDexCom Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$100.00 ➝ $82.005/18/2026DXCMDexCom BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingUnderweight$67.00 ➝ $64.005/18/2026AMZNAmazon.com Arete ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$301.00 ➝ $310.005/18/2026DXCMDexCom Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$100.00 ➝ $80.005/15/2026DXCMDexCom William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy5/13/2026AMZNAmazon.com Phillip SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeModerate Buy ➝ Buy$280.005/12/2026AMZNAmazon.com TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$350.005/11/2026DXCMDexCom BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$77.005/11/2026DXCMDexCom BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy5/6/2026AMZNAmazon.com Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B-) ➝ Buy (B)(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMZNAmazon.com$716.92B4.02$13.52 per share19.83$41.08 per share6.53DXCMDexCom$4.82B5.79$2.80 per share25.80$7.66 per share9.43Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMZNAmazon.com$77.67B$8.3632.0626.751.9812.22%19.92%9.86%7/30/2026 (Estimated)DXCMDexCom$836.30M$2.3431.0023.921.1819.31%33.33%13.19%7/29/2026 (Estimated)Latest DXCM and AMZN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2026Q1 2026DXCMDexCom$0.47$0.56+$0.09$0.51$1.17 billion$1.19 billion4/29/2026Q1 2026AMZNAmazon.com$1.63$2.78+$1.15$2.78$177.28 billion$181.52 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAMZNAmazon.comN/AN/AN/AN/AN/ADXCMDexComN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMZNAmazon.com0.271.181.01DXCMDexCom0.421.951.64Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMZNAmazon.com72.20%DXCMDexCom97.75%Insider OwnershipCompanyInsider OwnershipAMZNAmazon.com8.90%DXCMDexCom0.28%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMZNAmazon.com1,576,00010.76 billion9.80 billionOptionableDXCMDexCom11,000385.87 million384.79 millionOptionableDXCM and AMZN HeadlinesRecent News About These CompaniesHarnessing medtech market alliances, ŌURA sets IPO plans in motion29 minutes ago | medicaldevice-network.comMAnalysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share RecoveryMay 22 at 8:51 AM | insidermonkey.comAnalysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share RecoveryMay 22 at 8:48 AM | finance.yahoo.comRathbones Group PLC Sells 18,632 Shares of DexCom, Inc. $DXCMMay 22 at 5:46 AM | marketbeat.comFideuram Intesa Sanpaolo Private Banking S.P.A. Makes New $1.86 Million Investment in DexCom, Inc. $DXCMMay 22 at 3:57 AM | marketbeat.comDexCom Might Finally Be Cheap EnoughMay 21 at 10:10 PM | seekingalpha.comLeonteq Securities AG Takes $2.12 Million Position in DexCom, Inc. $DXCMMay 21 at 6:26 AM | marketbeat.comHandelsbanken Fonder AB Sells 230,974 Shares of DexCom, Inc. $DXCMMay 21 at 5:14 AM | marketbeat.comLive Longer and Better. Does Medicine’s New Obsession Really Work?May 21 at 2:56 AM | finance.yahoo.comThe DexCom Stock Turnaround Is Showing Real Signs of LifeMay 20 at 1:51 PM | barchart.comHere's Why DexCom (DXCM) is a Strong Momentum StockMay 20 at 10:50 AM | zacks.comInsider Selling: DexCom (NASDAQ:DXCM) EVP Sells 1,700 Shares of StockMay 20 at 6:49 AM | insidertrades.comThrivent Financial for Lutherans Cuts Stock Position in DexCom, Inc. $DXCMMay 20 at 6:48 AM | marketbeat.comMarble Harbor Investment Counsel LLC Sells 39,376 Shares of DexCom, Inc. $DXCMMay 20 at 5:50 AM | marketbeat.comProShare Advisors LLC Buys 190,461 Shares of DexCom, Inc. $DXCMMay 20 at 5:15 AM | marketbeat.comNorth Dakota State Investment Board Makes New Investment in DexCom, Inc. $DXCMMay 20 at 4:58 AM | marketbeat.comDXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in GermanyMay 19 at 12:43 PM | finance.yahoo.comDXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in GermanyMay 19 at 11:58 AM | zacks.comBarclays Sticks to Its Sell Rating for Dexcom (DXCM)May 19 at 7:25 AM | theglobeandmail.comDexCom (NASDAQ:DXCM) Given New $80.00 Price Target at Bank of AmericaMay 19 at 3:25 AM | americanbankingnews.comWearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and MasimoMay 18, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAmazon’s Earnings Just Sent the Stock to New Highs—What’s Next?By Sam Quirke | April 30, 2026Amazon Weaponizes Logistics, Triggering Sector-Wide SelloffBy Jeffrey Neal Johnson | May 5, 2026Just How Big a Problem Could Amazon’s Cash Burn Rate Be?By Sam Quirke | May 6, 20263 Reasons Analysts Love DexComBy Nathan Reiff | May 5, 2026Why Trump’s Amazon Stock Sale May Not Matter at AllBy Sam Quirke | May 19, 2026DXCM and AMZN Company DescriptionsAmazon.com NASDAQ:AMZN$268.06 -0.40 (-0.15%) As of 02:42 PM Eastern This is a fair market value price provided by Massive. Learn more.Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. Amazon.com, Inc. was incorporated in 1994 and is headquartered in Seattle, Washington.DexCom NASDAQ:DXCM$72.24 +0.34 (+0.48%) As of 02:42 PM Eastern This is a fair market value price provided by Massive. Learn more.DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Intuit's Great SaaS Reset: Fired By AI Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish Target Shows Strengths, But Analysts Want to See More Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
